These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1546547)

  • 41. Diagnosis and treatment of premenstrual dysphoric disorder: an update.
    Steiner M; Born L
    Int Clin Psychopharmacol; 2000 Nov; 15 Suppl 3():S5-17. PubMed ID: 11195269
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fluoxetine in the treatment of premenstrual dysphoria.
    Su TP; Schmidt PJ; Danaceau MA; Tobin MB; Rosenstein DL; Murphy DL; Rubinow DR
    Neuropsychopharmacology; 1997 May; 16(5):346-56. PubMed ID: 9109106
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fluvoxamine for premenstrual dysphoric disorder: a pilot study.
    Freeman EW; Rickels K; Sondheimer SJ
    J Clin Psychiatry; 1996; 57 Suppl 8():56-9; discussion 60. PubMed ID: 8698682
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A randomized, placebo-controlled, crossover trial of danazol for the treatment of premenstrual syndrome.
    Hahn PM; Van Vugt DA; Reid RL
    Psychoneuroendocrinology; 1995; 20(2):193-209. PubMed ID: 7899538
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Differential response to estrogen challenge test in women with and without premenstrual dysphoria.
    Eriksson O; Bäckström T; Stridsberg M; Hammarlund-Udenaes M; Naessén T
    Psychoneuroendocrinology; 2006 May; 31(4):415-27. PubMed ID: 16359822
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Luteal phase treatment of premenstrual dysphoric disorder improves symptoms that continue into the postmenstrual phase.
    Yonkers KA; Pearlstein T; Fayyad R; Gillespie JA
    J Affect Disord; 2005 Apr; 85(3):317-21. PubMed ID: 15780701
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Premenstrual symptoms and perimenopausal depression.
    Richards M; Rubinow DR; Daly RC; Schmidt PJ
    Am J Psychiatry; 2006 Jan; 163(1):133-7. PubMed ID: 16390900
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Diagnostic and therapeutic algorithm for the treatment of premenstrual dysphoric disorder].
    Strkalj Ivezić S; Kusan Jukić M; Tikvica A; Pavicić Baldani D
    Acta Med Croatica; 2010 Jul; 64(3):183-90. PubMed ID: 20922861
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pyridoxine (vitamin B6) and the premenstrual syndrome: a randomized crossover trial.
    Doll H; Brown S; Thurston A; Vessey M
    J R Coll Gen Pract; 1989 Sep; 39(326):364-8. PubMed ID: 2558186
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Myo-inositol has no beneficial effect on premenstrual dysphoric disorder.
    Nemets B; Talesnick B; Belmaker RH; Levine J
    World J Biol Psychiatry; 2002 Jul; 3(3):147-9. PubMed ID: 12478879
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment of premenstrual syndrome with fluoxetine: a double-blind, placebo-controlled, crossover study.
    Wood SH; Mortola JF; Chan YF; Moossazadeh F; Yen SS
    Obstet Gynecol; 1992 Sep; 80(3 Pt 1):339-44. PubMed ID: 1495689
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Treatment of premenstrual depression with nortriptyline: a pilot study.
    Harrison WM; Endicott J; Nee J
    J Clin Psychiatry; 1989 Apr; 50(4):136-9. PubMed ID: 2647713
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Fluoxetine in the treatment of premenstrual syndrome.
    Stone AB; Pearlstein TB; Brown WA
    Psychopharmacol Bull; 1990; 26(3):331-5. PubMed ID: 2274633
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Duloxetine treatment for women with premenstrual dysphoric disorder: a single-blind trial.
    Ramos MG; Hara C; Rocha FL
    Int J Neuropsychopharmacol; 2009 Sep; 12(8):1081-8. PubMed ID: 19250561
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treatment of premenstrual syndrome with gonadotropin-releasing hormone agonist in a low dose regimen.
    Sundström I; Nyberg S; Bixo M; Hammarbäck S; Bäckström T
    Acta Obstet Gynecol Scand; 1999 Nov; 78(10):891-9. PubMed ID: 10577620
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatment of premenstrual syndrome with alprazolam: results of a double-blind, placebo-controlled, randomized crossover clinical trial.
    Smith S; Rinehart JS; Ruddock VE; Schiff I
    Obstet Gynecol; 1987 Jul; 70(1):37-43. PubMed ID: 3299178
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Depression, irritability, and anxiety in women with premenstrual dysphoric disorder.
    Ko CH; Long CY; Chen SY; Chen IJ; Huang TH; Yen JY
    Int J Psychiatry Med; 2013; 46(1):39-55. PubMed ID: 24547609
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sertraline in the treatment of premenstrual dysphoric disorder.
    Yonkers KA; Halbreich U; Freeman E; Brown C; Pearlstein T
    Psychopharmacol Bull; 1996; 32(1):41-6. PubMed ID: 8927673
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of a unique oral contraceptive (Yasmin) in the management of premenstrual dysphoric disorder.
    Freeman EW
    Eur J Contracept Reprod Health Care; 2002 Dec; 7 Suppl 3():27-34; discussion 42-3. PubMed ID: 12659404
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A double-blind placebo-controlled trial of progesterone vaginal suppositories in the treatment of premenstrual syndrome.
    Maddocks S; Hahn P; Moller F; Reid RL
    Am J Obstet Gynecol; 1986 Mar; 154(3):573-81. PubMed ID: 3513587
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.